Global Mycoplasma Testing Market Size Study & Forecast, by Product (Instruments, Kits & Reagents) and Technology (PCR, ELISA, Direct Assay, Microbial Culture) and Regional Forecasts 2022-2032

Description

The Global Mycoplasma Testing Market is estimated to be valued at approximately USD 1.07 billion in 2024 and is projected to expand robustly at a CAGR of 13.58% during the forecast period spanning 2025 to 2035. Mycoplasma testing plays a pivotal role in the pharmaceutical and biotechnology industries, ensuring the safety and purity of biological products by detecting contamination that can adversely affect research outcomes and therapeutic applications. These tests employ sophisticated methodologies ranging from PCR to microbial culture techniques, serving as critical tools in quality control for cell culture, vaccine manufacturing, and biopharmaceutical production. The market's growth is largely propelled by heightened regulatory scrutiny, increasing R&D investments, and the expanding biopharmaceutical sector's demand for stringent contamination control protocols.

Escalating incidences of contamination in biologics production, alongside rising awareness regarding the adverse impacts of mycoplasma infections on cell cultures, have accelerated the adoption of advanced testing methods. Technological innovations, such as real-time PCR and ELISA, have enhanced the accuracy and speed of detection, thereby supporting the burgeoning need for rapid and reliable screening. Additionally, the surge in contract research organizations (CROs) and the growing emphasis on vaccine development, especially in the wake of global health emergencies, have further underscored the importance of mycoplasma testing. However, challenges such as high testing costs and the availability of alternative contamination control measures might temper the market's growth trajectory.

Regionally, North America commands a dominant position in the global Mycoplasma Testing Market, buoyed by its well-established pharmaceutical industry, rigorous regulatory framework, and significant expenditure on biotechnology R&D. The U.S., in particular, serves as a major hub due to its advanced healthcare infrastructure and presence of key market players. Europe follows closely, driven by countries like Germany, the UK, and France, where stringent quality standards and increasing biopharmaceutical manufacturing activities prevail. Meanwhile, the Asia Pacific region is anticipated to witness the fastest growth owing to escalating healthcare investments, expanding biotechnology hubs in China and India, and supportive government initiatives fostering research and innovation. Latin America and the Middle East & Africa, though smaller markets currently, are poised for gradual growth fueled by rising healthcare awareness and infrastructural development.

Major market players included in this report are:

Thermo Fisher Scientific Inc.
Merck KGaA
Bio-Rad Laboratories, Inc.
Lonza Group Ltd.
Qiagen N.V.
Charles River Laboratories International, Inc.
PerkinElmer, Inc.
Agilent Technologies, Inc.
Roche Diagnostics
Abbott Laboratories
Greiner Bio-One International GmbH
Tecan Group Ltd.
Eurofins Scientific SE
Danaher Corporation
Sartorius AG

Global Mycoplasma Testing Market Report Scope:

Historical Data - 2023, 2024
Base Year for Estimation - 2024
Forecast Period - 2025-2035
Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
Customization Scope - Free report customization (equivalent up to 8 analysts' working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values for the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within the countries involved in the study. The report also provides detailed information about crucial aspects, such as driving factors and challenges, which will define the future growth of the market. Additionally, it incorporates potential opportunities in micro-markets for stakeholders to invest, along with a detailed analysis of the competitive landscape and product offerings of key players. The detailed segments and sub-segments of the market are explained below:

By Product:

Instruments
Kits & Reagents

By Technology:

PCR
ELISA
Direct Assay
Microbial Culture

By Application:

(Various industry-specific applications to be defined based on available data)

By End-Use:

(Clinical laboratories, pharmaceutical & biotechnology companies, contract research organizations, others)

By Region:

North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
Rest of Europe (ROE)
Asia Pacific
China
India
Japan
Australia
South Korea
Rest of Asia Pacific (RoAPAC)
Latin America
Brazil
Mexico
Middle East & Africa
UAE
Saudi Arabia
South Africa
Rest of Middle East & Africa

Key Takeaways:

Market Estimates & Forecast for 10 years from 2025 to 2035.
Annualized revenues and regional level analysis for each market segment.
Detailed analysis of geographical landscape with Country level analysis of major regions.
Competitive landscape with information on major players in the market.
Analysis of key business strategies and recommendations on future market approach.
Analysis of competitive structure of the market.
Demand side and supply side analysis of the market.

Chapter 1. Global Mycoplasma Testing Market Report Scope & Methodology

1.1. Research Objective
1.2. Research Methodology
- 1.2.1. Forecast Model
- 1.2.2. Desk Research
- 1.2.3. Top Down and Bottom-Up Approach
1.3. Research Attributes
1.4. Scope of the Study
- 1.4.1. Market Definition
- 1.4.2. Market Segmentation
1.5. Research Assumption
- 1.5.1. Inclusion & Exclusion
- 1.5.2. Limitations
- 1.5.3. Years Considered for the Study

Chapter 2. Executive Summary

2.1. CEO/CXO Standpoint
2.2. Strategic Insights
2.3. ESG Analysis
2.4. Key Findings

Chapter 3. Global Mycoplasma Testing Market Forces Analysis

3.1. Market Forces Shaping The Global Mycoplasma Testing Market (2024-2035)
3.2. Drivers
- 3.2.1. Increasing Biopharmaceutical Production & Heightened Regulatory Scrutiny (Key Driver)
- 3.2.2. Technological Advancements in Molecular Diagnostics (Real-time PCR, ELISA, Rapid Assays) (Key Driver)
3.3. Restraints
- 3.3.1. High Testing Costs and Infrastructure Gaps in Emerging Regions (Key Restraint)
- 3.3.2. Limited Skilled Personnel and Lack of Standardized Protocols (Key Restraint)
3.4. Opportunities
- 3.4.1. Expansion of Testing Capacity in Asia Pacific & Emerging Markets (Key Opportunity)
- 3.4.2. Automation, High-throughput Platforms, and Point-of-Care Mycoplasma Solutions (Key Opportunity)

Chapter 4. Global Mycoplasma Testing Industry Analysis

4.1. Porter's 5 Forces Model
- 4.1.1. Bargaining Power of Buyer
- 4.1.2. Bargaining Power of Supplier
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
4.2. Porter's 5 Force Forecast Model (2024-2035)
4.3. PESTEL Analysis
- 4.3.1. Political
- 4.3.2. Economical
- 4.3.3. Social
- 4.3.4. Technological
- 4.3.5. Environmental
- 4.3.6. Legal
4.4. Top Investment Opportunities
4.5. Top Winning Strategies (2025)
4.6. Market Share Analysis (2024-2025)
4.7. Global Pricing Analysis And Trends 2025
4.8. Analyst Recommendation & Conclusion

Chapter 5. Global Mycoplasma Testing Market Size & Forecasts by Product 2025-2035

5.1. Market Overview
5.2. Global Mycoplasma Testing Market Performance - Potential Analysis (2025)
5.3. Instruments
- 5.3.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 5.3.2. Market size analysis, by region, 2025-2035
5.4. Kits & Reagents
- 5.4.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 5.4.2. Market size analysis, by region, 2025-2035

Chapter 6. Global Mycoplasma Testing Market Size & Forecasts by Technology 2025-2035

6.1. Market Overview
6.2. Global Mycoplasma Testing Market Performance - Potential Analysis (2025)
6.3. PCR
- 6.3.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 6.3.2. Market size analysis, by region, 2025-2035
6.4. ELISA
- 6.4.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 6.4.2. Market size analysis, by region, 2025-2035
6.5. Direct Assay
- 6.5.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 6.5.2. Market size analysis, by region, 2025-2035
6.6. Microbial Culture
- 6.6.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 6.6.2. Market size analysis, by region, 2025-2035

Chapter 7. Global Mycoplasma Testing Market Size & Forecasts by Region 2025-2035

7.1. Mycoplasma Testing Market, Regional Market Snapshot
7.2. Top Leading & Emerging Countries
7.3. North America Mycoplasma Testing Market
- 7.3.1. U.S. Mycoplasma Testing Market
  - 7.3.1.1. Product/Technology breakdown size & forecasts, 2025-2035
  - 7.3.1.2. End-use breakdown size & forecasts, 2025-2035
- 7.3.2. Canada Mycoplasma Testing Market
  - 7.3.2.1. Product/Technology breakdown size & forecasts, 2025-2035
  - 7.3.2.2. End-use breakdown size & forecasts, 2025-2035
7.4. Europe Mycoplasma Testing Market
- 7.4.1. UK Mycoplasma Testing Market
  - 7.4.1.1. Product/Technology breakdown size & forecasts, 2025-2035
  - 7.4.1.2. End-use breakdown size & forecasts, 2025-2035
- 7.4.2. Germany Mycoplasma Testing Market
  - 7.4.2.1. Product/Technology breakdown size & forecasts, 2025-2035
  - 7.4.2.2. End-use breakdown size & forecasts, 2025-2035
- 7.4.3. France Mycoplasma Testing Market
  - 7.4.3.1. Product/Technology breakdown size & forecasts, 2025-2035
  - 7.4.3.2. End-use breakdown size & forecasts, 2025-2035
- 7.4.4. Spain Mycoplasma Testing Market
  - 7.4.4.1. Product/Technology breakdown size & forecasts, 2025-2035
  - 7.4.4.2. End-use breakdown size & forecasts, 2025-2035
- 7.4.5. Italy Mycoplasma Testing Market
  - 7.4.5.1. Product/Technology breakdown size & forecasts, 2025-2035
  - 7.4.5.2. End-use breakdown size & forecasts, 2025-2035
- 7.4.6. Rest of Europe Mycoplasma Testing Market
  - 7.4.6.1. Product/Technology breakdown size & forecasts, 2025-2035
  - 7.4.6.2. End-use breakdown size & forecasts, 2025-2035
7.5. Asia Pacific Mycoplasma Testing Market
- 7.5.1. China Mycoplasma Testing Market
  - 7.5.1.1. Product/Technology breakdown size & forecasts, 2025-2035
  - 7.5.1.2. End-use breakdown size & forecasts, 2025-2035
- 7.5.2. India Mycoplasma Testing Market
  - 7.5.2.1. Product/Technology breakdown size & forecasts, 2025-2035
  - 7.5.2.2. End-use breakdown size & forecasts, 2025-2035
- 7.5.3. Japan Mycoplasma Testing Market
  - 7.5.3.1. Product/Technology breakdown size & forecasts, 2025-2035
  - 7.5.3.2. End-use breakdown size & forecasts, 2025-2035
- 7.5.4. Australia Mycoplasma Testing Market
  - 7.5.4.1. Product/Technology breakdown size & forecasts, 2025-2035
  - 7.5.4.2. End-use breakdown size & forecasts, 2025-2035
- 7.5.5. South Korea Mycoplasma Testing Market
  - 7.5.5.1. Product/Technology breakdown size & forecasts, 2025-2035
  - 7.5.5.2. End-use breakdown size & forecasts, 2025-2035
- 7.5.6. Rest of APAC Mycoplasma Testing Market
  - 7.5.6.1. Product/Technology breakdown size & forecasts, 2025-2035
  - 7.5.6.2. End-use breakdown size & forecasts, 2025-2035
7.6. Latin America Mycoplasma Testing Market
- 7.6.1. Brazil Mycoplasma Testing Market
  - 7.6.1.1. Product/Technology breakdown size & forecasts, 2025-2035
  - 7.6.1.2. End-use breakdown size & forecasts, 2025-2035
- 7.6.2. Mexico Mycoplasma Testing Market
  - 7.6.2.1. Product/Technology breakdown size & forecasts, 2025-2035
  - 7.6.2.2. End-use breakdown size & forecasts, 2025-2035
7.7. Middle East and Africa Mycoplasma Testing Market
- 7.7.1. UAE Mycoplasma Testing Market
  - 7.7.1.1. Product/Technology breakdown size & forecasts, 2025-2035
  - 7.7.1.2. End-use breakdown size & forecasts, 2025-2035
- 7.7.2. Saudi Arabia (KSA) Mycoplasma Testing Market
  - 7.7.2.1. Product/Technology breakdown size & forecasts, 2025-2035
  - 7.7.2.2. End-use breakdown size & forecasts, 2025-2035
- 7.7.3. South Africa Mycoplasma Testing Market
  - 7.7.3.1. Product/Technology breakdown size & forecasts, 2025-2035
  - 7.7.3.2. End-use breakdown size & forecasts, 2025-2035

Chapter 8. Competitive Intelligence

8.1. Top Market Strategies
8.2. Thermo Fisher Scientific Inc.
- 8.2.1. Company Overview
- 8.2.2. Key Executives
- 8.2.3. Company Snapshot
- 8.2.4. Financial Performance (Subject to Data Availability)
- 8.2.5. Product/Services Port
- 8.2.6. Recent Development
- 8.2.7. Market Strategies
- 8.2.8. SWOT Analysis
8.3. Merck KGaA
8.4. Bio-Rad Laboratories, Inc.
8.5. Lonza Group Ltd.
8.6. Qiagen N.V.
8.7. Charles River Laboratories International, Inc.
8.8. PerkinElmer, Inc.
8.9. Agilent Technologies, Inc.
8.10. Roche Diagnostics
8.11. Abbott Laboratories
8.12. Greiner Bio-One International GmbH
8.13. Tecan Group Ltd.
8.14. Eurofins Scientific SE
8.15. Danaher Corporation
8.16. Sartorius AG